Nicotine-induced activation of cholinergic receptor nicotinic alpha 5 subunit mediates the malignant behaviours of laryngeal squamous epithelial cells by interacting with RABL6

Yujie Shen,Qiang Huang,Xiaohui Yuan,Hongli Gong,Chengzhi Xu,Huaidong Du,Chi-Yao Hsueh,Liang Zhou

DOI: https://doi.org/10.1038/s41420-024-02051-x

2024-06-16

Cell Death Discovery

Abstract:Nicotine, a crucial constituent of tobacco smoke, can bind to and activate nicotinic acetylcholine receptors (nAChRs), thereby regulating various biological functions. However, the specific mechanisms through which nicotine mediates nAChRs to regulate the metastasis of laryngeal squamous cell carcinoma (LSCC) remain elusive. In this study, smoking status was found to be closely associated with metastasis in patients with LSCC. In addition, nicotine exposure potentiated the hematogenous and lymphatic metastatic capacity of LSCC cells. Nicotine activates membrane-bound CHRNA5, promoting cell migration and invasion, EMT and cell–ECM adhesion in LSCC. Furthermore, this study demonstrated that the Ras superfamily protein RABL6 directly interacted with CHRNA5, which preferentially binds to the RABL6-39-279aa region, and this interaction was enhanced by nicotine. Nicotine-mediated activation of CHRNA5 enhanced its interaction with RABL6, triggering the JAK2/STAT3 signalling pathway and eventually augmenting the metastatic potential of LSCC cells. This study reveals a novel mechanism through which nicotine-mediated CHRNA5–RABL6 interaction promotes the metastasis of LSCC. The findings of this study may help to develop effective strategies for improving the outcome of patients with LSCC in clinical settings.

cell biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore how nicotine promotes the malignant behavior of laryngeal squamous cell carcinoma (LSCC), especially its metastatic ability, by activating the α5 subunit nicotinic acetylcholine receptor (CHRNA5) to interact with the RABL6 protein. Specifically, the study aims to reveal how nicotine affects the migration, invasion, epithelial - mesenchymal transition (EMT) and cell - extracellular matrix (ECM) adhesion of LSCC cells through this mechanism, and ultimately enhances the metastatic potential of LSCC. ### Research Background - **Laryngeal Squamous Cell Carcinoma (LSCC)**: LSCC is a type of head and neck squamous cell carcinoma (HNSCC), which mainly occurs in the larynx and accounts for more than 95% of all malignant laryngeal cancers. The early symptoms are not obvious, leading to difficult diagnosis, and most patients are diagnosed in the middle - late stage with a poor prognosis. - **The Influence of Smoking**: Smoking is the main risk factor for LSCC, and about 70 - 80% of LSCC cases are related to smoking and drinking. Nicotine, as a key component in tobacco, has regulatory effects on various biological functions, but the specific mechanism is still unclear. ### Research Methods - **Cell Experiments**: Through in vitro experiments, the effects of nicotine on the proliferation, migration and invasion abilities of LSCC cells were studied, and the changes in the expression of related proteins were detected. - **Animal Models**: Mouse models of tail vein metastasis and inguinal lymph node metastasis were established to evaluate the influence of smoking on the metastatic ability of LSCC cells. - **Molecular Mechanisms**: Through co - immunoprecipitation (Co - IP), mass spectrometry (MS) and molecular docking techniques, the interaction between CHRNA5 and RABL6 and its influence on LSCC metastasis were explored. ### Main Findings - **Nicotine Promotes LSCC Metastasis**: Nicotine enhances the migration, invasion and EMT abilities of LSCC cells, as well as the cell - ECM adhesion ability by activating CHRNA5. - **The Interaction between CHRNA5 and RABL6**: CHRNA5 directly binds to RABL6, especially the 39 - 279 amino acid region of RABL6. Nicotine further enhances this interaction. - **JAK2/STAT3 Signaling Pathway**: The interaction between CHRNA5 and RABL6 triggers the activation of the JAK2/STAT3 signaling pathway, thereby enhancing the metastatic potential of LSCC cells. ### Conclusion This study reveals a new mechanism by which nicotine promotes LSCC metastasis by activating CHRNA5 and interacting with RABL6. These findings are helpful for developing more effective strategies to improve the clinical prognosis of LSCC patients.

Nicotine-induced activation of cholinergic receptor nicotinic alpha 5 subunit mediates the malignant behaviours of laryngeal squamous epithelial cells by interacting with RABL6

Nicotine Enhances Invasion and Metastasis of Human Colorectal Cancer Cells Through the Nicotinic Acetylcholine Receptor Downstream P38 MAPK Signaling Pathway.

Nicotine downregulates miR-375–3p via neurotrophic tyrosine receptor kinase 2 to enhance the malignant behaviors of laryngopharyngeal squamous epithelial cells

Activation of 5-Lipoxygenase is Required for Nicotine Mediated Epithelial-Mesenchymal Transition and Tumor Cell Growth

Abstract 7581: Nicotine promotes the proliferation and metastasis of non-small cell lung cancer through c-Myc/EZH2 pathway

Nicotine-induced CHRNA5 activation modulates CES1 expression, impacting head and neck squamous cell carcinoma recurrence and metastasis via MEK/ERK pathway

The role of α5-nicotinic acetylcholine receptor/NLRP3 signaling pathway in lung adenocarcinoma cell proliferation and migration

Nicotine Promotes the Development of Non-Small Cell Lung Cancer Through Activating LINC00460 and PI3K/Akt Signaling

From tobacco smoking to mutational signature: the role of epigenetic changes in human cancers

Cigarette smoking, by accelerating the cell cycle, promotes the progression of non-small cell lung cancer through an HIF-1α-METTL3-m 6 A/CDK2AP2 axis

Low-Dose Nicotine Activates EGFR Signaling via α5-nAChR and Promotes Lung Adenocarcinoma Progression

Nicotine promotes M2 macrophage polarization through α5-nAChR/SOX2/CSF-1 axis in lung adenocarcinoma

Nicotine activates HIF-1α and regulates acid extruders through the nicotinic acetylcholine receptor to promote the Warburg effect in non-small cell lung cancer cells

Smoking behavior associated upregulation of SERPINB12 promotes proliferation and metastasis via activating WNT signaling in NSCLC

Nicotine-mediated cell proliferation and tumor progression in smoking-related cancers

Smoking-mediated Nicotinic Acetylcholine Receptors (nachrs) for Predicting Outcomes for Head and Neck Squamous Cell Carcinomas.

Abstract 5521: Nicotine promotes perineural brain metastasis of lung cancer by activating GABAergic neurons

α9- and α7-containing receptors mediate the pro-proliferative effects of nicotine in the A549 adenocarcinoma cell line

Smoking-induced CCNA2 expression promotes lung adenocarcinoma tumorigenesis by boosting AT2/AT2-like cell differentiation

Repurposing dextromethorphan and metformin for treating nicotine-induced cancer by directly targeting CHRNA7 to inhibit JAK2/STAT3/SOX2 signaling

Expression patterns for nicotinic acetylcholine receptor subunit genes in smoking-related lung cancers